Informed consent was not included in the published version of the following articles that appeared in previous issues of Leukemia Research Reports.
The appropriate informed consent statements, provided by the authors, are included below:
-
1
“Acute aleukemic mast cell leukemia: Report of a case and review of the literature” [Leukemia Research Reports, 2020; 14C: 100230] 10.1016/j.lrr.2020.100230.
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
1
“Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size” Leukemia Research Reports, 2020; 13C: 100202] 10.1016/j.lrr.2020.100202.
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
1
“T315I-mutated myeloid sarcoma” [Leukemia Research Reports, 2019; 12C: 100184] 10.1016/j.lrr.2019.100184.
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features” [Leukemia Research Reports, 2019; 12C: 100186] 10.1016/j.lrr.2019.100186.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Cytomegalovirus reactivation triggers the late onset of hyperthyroidism after autologous peripheral blood transplantation” [Leukemia Research Reports, 2019; 11C: 5-7] 10.1016/j.lrr.2018.11.002.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia” [Leukemia Research Reports, 2019; 11C: 8-10] 10.1016/j.lrr.2019.03.001.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Effective maintenance treatment with lenalidomide for a patient with aggressive adult T cell leukemia after chemotherapy” [Leukemia Research Reports, 2019; 11C: 21-23] 10.1016/j.lrr.2019.04.001.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience” [Leukemia Research Reports, 2019; 11C: 27-30] 10.1016/j.lrr.2019.04.003.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement” [Leukemia Research Reports, 2019; 11C: 31-33] 10.1016/j.lrr.2019.04.005.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“A rare case of near-haploid acute lymphoblastic leukemia” [Leukemia Research Reports, 2019; 11C: 34-37] 10.1016/j.lrr.2019.04.006.
-
1
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
“Fatal infection with enterocolitis from methicillin-resistant Staphylococcus aureus and the continued value of culture in the era of molecular diagnostics” [Leukemia Research Reports, 2021; 15C: 100254] 10.1016/j.lrr.2021.100254.
-
1
Informed consent: This case report did not contain personally identifiable information and the review of other cases utilized de-identified data. Therefore, this was deemed to be non-research and exempt from requiring Institutional Review Board review.